11-KETO-BETA-BOSWELLIC ACID

Bezeichnung:11-KETO-BETA-BOSWELLIC ACID

CAS-Nr17019-92-0

Englisch Name:11-KETO-BETA-BOSWELLIC ACID

CBNumberCB1415526

SummenformelC30H46O4

Molgewicht470.68

MOL-Datei17019-92-0.mol

11-KETO-BETA-BOSWELLIC ACID physikalisch-chemischer Eigenschaften

Schmelzpunkt	190～192℃
Siedepunkt	591.8±50.0 °C(Predicted)
Dichte	1.14±0.1 g/cm3(Predicted)
storage temp.	4°C, protect from light
Löslichkeit	≤5mg/ml in ethanol;25mg/ml in DMSO;25mg/ml in dimethyl formamide
pka	4.46±0.70(Predicted)
Aggregatzustand	Solid
Farbe	White
Wasserlöslichkeit	insoluble in water
InChIKey	YIMHGPSYDOGBPI-IQQSWPBXSA-N
LogP	7.100 (est)

Sicherheit

WGK Germany	3
HS Code	29189900

11-KETO-BETA-BOSWELLIC ACID Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden
A constitutent of frankincense (olibanum) with anti-inflammatory properties. It has been shown to trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells.
Biologische Aktivität
37.9 μm: blocks a2780 (cis-platin resistant ovarian cancer cells) [1].11-keto-β-boswellic acid, known as kba, is a naturally occurring pentacyclic triterpene isolated from the gum resin of the tree boswellia serrata. kba is non-redox, specific leukotriene synthesis inhibitors through the inhibition of 5-lipoxygenase (5-lox) which has anti-arthritic and anti-inflammatory activities. 5-lox catalyzes essential fatty acids substrates into leukotrienes and a variety of other biologically active products. kba is a novel activator of nuclear factor erythroid-2-related factor 2 (nrf2), which protects against cerebral ischemic injury.
in vitro
kba, concentration dependently, decreased the formation of leukotriene b4 and the synthesis of all 5-lox products from endogenous arachidonic acid in rat peritoneal neutrophils. in contrast, kba exerted no remarkable effects on the 12-lipoxygenase and cyclooxygenase activities. [2].
in vivo
adult male sprague–dawley rats were injected kab intraperitoneally at a dose of 25 mg/kg for 48 hours. kab remarkably decreased infarct volumes as well as apoptotic cells at 1 h, and then increased neurologic scores when applied 48 h. moreover, posttreatment with kba induced the decrease of malondialdehyde levels and the increase of protein nrf2 and heme oxygenase-1 expression in brain tissues, indicating that the nrf2/ho-1 pathway was involved in the neuroprotection of kba against oxidative stress-induced ischemic injury [3].
IC 50
35.8 μm: inhibits mcf-7 (human breast adenocarcinoma) [1].
Einzelnachweise
[1]. csuk, r., barthel-niesen, a., barthel, a., schffer, r., & al-harrasi, a. 11-keto-boswellic acid derived amides and monodesmosidic saponins induce apoptosis in breast and cervical cancers cells. european journal of medicinal chemistry. 2015; 100: 98-105.
[2]. safayhi, h., mack, t. h. o. m. a. s., sabieraj, j. o. a. c. h. i. m., anazodo, m. i., subramanian, l. r., & ammon, h. p. boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. journal of pharmacology and experimental therapeutics. 1992; 261(3):1143-1146.
[3]. ding, y., chen, m., wang, m., li, y., & wen, a. posttreatment with 11-keto-β-boswellic acid ameliorates cerebral ischemia–reperfusion injury: nrf2/ho-1 pathway as a potential mechanism. molecular neurobiology. 2014; 52(3): 1430-1439.

11-KETO-BETA-BOSWELLIC ACID Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

17019-92-0, 11-KETO-BETA-BOSWELLIC ACID Verwandte Suche:

Send Inquriy